Innovative Approach: Sequestering Gut Bacteria's Microbial Fuel Improves Blood Sugar and Liver Health

New research reveals that trapping a microbial fuel from gut bacteria can significantly improve blood sugar control and liver health, opening new possibilities for treating metabolic diseases like diabetes and fatty liver disease.
Recent research from Canadian scientists has unveiled a groundbreaking method to enhance metabolic health by targeting a microbial-derived fuel in the gut. The study, published in Cell Metabolism, highlights how a molecule produced by gut microbiota can enter the bloodstream and promote excessive glucose and fat production in the liver, contributing to conditions like type 2 diabetes and fatty liver disease.
Researchers at McMaster University, Université Laval, and the University of Ottawa discovered that obese mice—and humans with obesity—exhibit elevated levels of D-lactate, a less common form of lactate originating primarily from gut bacteria. Unlike the well-known L-lactate produced by muscles, D-lactate was found to more aggressively raise blood sugar and liver fat.
The team developed a novel "gut substrate trap"—a biodegradable polymer that binds to D-lactate within the gut, preventing its absorption into the bloodstream. When administered to mice, this trap significantly lowered blood glucose levels, improved insulin sensitivity, and reduced liver inflammation and fibrosis—all without altering their diet or body weight.
Professor Jonathan Schertzer, the senior author, explained that this discovery introduces a new dimension to understanding metabolic pathways, extending the classic Cori cycle, which involves the exchange of lactate and glucose between muscles and the liver. This research reveals a new branch involving gut bacteria, adding complexity to how metabolic signals are mediated.
The findings are significant because they present a novel therapeutic target—intercepting the microbial fuel before it causes harm. This approach shifts the focus from hormonal or organ-specific treatments to the microbiome itself, highlighting its role in chronic metabolic diseases.
This research underscores the growing recognition of the microbiome's influence on health and disease, offering promising new avenues for managing obesity-related conditions.
For more detailed information, view the full study in Cell Metabolism: link. Source: Medical Xpress.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Link Between Toxic Metals and Growth Challenges in Guatemalan Infants
New research links high levels of toxic metals in breast milk to growth impairments in infants in Guatemala, highlighting environmental pollution's impact on child health.
Cancer Cells Use Damaged Pancreatic Tissue to Promote Tumor Growth
New research uncovers how pancreatic tumor cells exploit damaged tissue to create favorable environments for growth, revealing potential pathways for targeted therapies.
Unexpected Role of Cancer-Related Gene in Pancreatic Tumor Growth
New research reveals that the cancer-fighting gene STK11 plays an unexpected role in supporting pancreatic tumor growth by regulating immune cell behavior. This discovery opens new avenues for targeted therapies against pancreatic cancer.
International Research Confirms Link Between Glyphosate and Multiple Cancers
A large-scale international study confirms that glyphosate, used at doses considered safe, is linked to multiple cancer types in rats, raising concerns about human health risks and regulatory standards.